Medtronic plc (MDT) stock analysis
Healthcare · Medical Devices
Revenue and net income by fiscal year
| Fiscal year | Revenue | Net income |
|---|---|---|
| 2023 | 31.2B | 3.8B |
| 2024 | 32.4B | 3.7B |
| 2025 | 33.5B | 4.7B |
| 2026 | 36.4B | 4.8B |
Price context
Over the last year Medtronic plc traded between 73.09 and 102.81, most recently 93.80.
How the verdict is built
Four independent models run on every company: a discounted cash flow, a revenue-driven growth DCF for businesses reinvesting everything into growth, valuation multiples against sector peers, and Graham with a dividend-discount model. They are weighted by the kind of business rather than averaged flat, so a cash-burning grower and a utility are not treated alike.
Strike Optics is an analytics and research tool for education. Nothing here is investment advice.
Other companies
All companies · Valuation glossary · Open the free tier, no account needed.